With increasing resource pressure, drug developers need to make more effective and informed go/no-go decisions as early as possible in the drug development process. Leading drug discovery and development companies are increasingly reorganizing their drug development process and programs to take advantage of these new tools and techniques to improve drug development pipeline productivity and focus resources on the most promising candidates.